Cohesin Polycomb Interactions in Gene Regulation
基因调控中的粘连蛋白多梳相互作用
基本信息
- 批准号:8990016
- 负责人:
- 金额:$ 29.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-01-01 至 2017-12-31
- 项目状态:已结题
- 来源:
- 关键词:Affinity ChromatographyAmino AcidsBindingBiochemicalBiochemical GeneticsBruck-de Lange syndromeCancer PrognosisCell divisionCellsChromatidsChromosome SegregationChromosomesComplexDataDefectDevelopmentDiagnosisDrosophila genusEnsureEpigenetic ProcessEquilibriumExcisionFluorescence Recovery After PhotobleachingGene ExpressionGene Expression RegulationGene SilencingGenesGeneticGenetic TranscriptionGenomic approachGenomicsGoalsGrowthGrowth and Development functionHealthHistonesHuman GeneticsIndividualKnowledgeLinkMalignant NeoplasmsMapsMessenger RNAMethodsModelingMolecularMutationOrganismPRC1 ProteinPatientsPhosphotransferasesPolycombPolymerasePositive Transcriptional Elongation Factor BProperdinProteinsProthrombinProto-OncogenesRNA Polymerase IIRecruitment ActivityRoleSister ChromatidSyndromeTestingTranscription Initiation SiteWorkbasebiophysical techniqueschromatin immunoprecipitationcohesincohesiondevelopmental diseasegenetic approachglobal run on sequencinghuman diseasein vivoinsightnegative elongation factornoveloutcome forecastprematurepreventpromoterresearch studytooltumortumor growth
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of the proposed work is to determine how sister chromatid cohesion proteins control gene transcription. This will illuminate mechanisms that underlie certain human genetic syndromes and cancers. Cohesin topologically encircles sister chromatids to hold them together until a cell divides. Moderate reductions in cohesin activity don't disrupt chromatid cohesion, but alter gene transcription, leading to poor growth and development. High cohesin activity is linked to poor prognosis in multiple cancers. How cohesin controls transcription is largely unknown, but current evidence argues that it participates directly in multiple mechanisms. Recent discoveries argue for a new paradigm in which a balance between cohesin and the Polycomb Repressive Complex 1 (PRC1) epigenetic silencing complex globally controls both gene silencing and transcription of many active genes. The data argue that cohesin directly facilitates binding of PRC1 to active genes, where PRC1 prevents paused RNA polymerase II (Pol II) at the promoter from prematurely entering into elongation. They also suggest that cohesin at active genes sequesters PRC1, thereby controlling how much is available for gene silencing, and that PRC1 limits cohesin binding at silenced and active genes. The goal of this proposal is to test this new paradigm, and determine the mechanisms by which cohesin and PRC1 together control both gene silencing and transcription of active genes. The proposed studies combine biochemical, genetic, genomic, and biophysical approaches to test key predictions of the current model. Aim 1 tests the ideas that cohesin physically interacts with PRC1 to directly facilitate PRC1 binding to active gene promoters, and that PRC1 limits cohesin binding through interactions with cohesin loading or removal factors. Aim 2 tests the idea that PRC1 prevents premature entry of paused Pol II into elongation by facilitating NELF and DSIF pausing factor or Pol II kinase activities. The insights into the mechanisms by which cohesin and PRC1 control transcription provided by these studies should suggest new methods for correcting cohesin-PRC1 imbalances in genetic syndromes and cancer.
描述(由申请人提供):拟议工作的长期目标是确定姐妹染色单体凝聚蛋白如何控制基因转录。这将阐明某些人类遗传综合征和癌症基础的机制。粘蛋白拓扑环绕姐妹染色单体将它们固定在一起,直到细胞分裂为止。粘着素活性的中度降低不会破坏染色单体的内聚力,而是改变基因转录,导致生长和发育差。高粘着素活性与多种癌症的预后不良有关。 粘着素如何控制转录的方式在很大程度上未知,但是当前的证据认为它直接参与了多种机制。最近的发现提出了一种新的范式,在这种范式中,粘蛋白与polycomb抑制性复合物1(PRC1)表观遗传沉默复合物全球控制着许多活性基因的基因沉默和转录。数据表明,粘着蛋白直接促进PRC1与活性基因的结合,在该基因中,PRC1阻止启动子处暂停的RNA聚合酶II(POL II)过早地伸长。他们还表明,在活性基因上的粘蛋白隔离PRC1,从而控制了多少可用于基因沉默,并且PRC1限制了在沉默和活性基因上粘着粘着蛋白的结合。该提案的目的是测试这种新范式,并确定粘蛋白和PRC1共同控制活性基因的基因沉默和转录的机制。 提出的研究结合了生化,遗传,基因组和生物物理方法,以测试当前模型的关键预测。 AIM 1测试了与PRC1物理相互作用的思想,以直接促进PRC1与活性基因启动子的结合,并且PRC1通过与粘蛋白负荷或去除因子相互作用而限制了粘蛋白结合。 AIM 2测试了PRC1通过促进NELF和DSIF暂停因子或Pol II激酶活动来阻止PRC1过早进入延伸的想法。这些研究提供的粘蛋白和PRC1对照转录的机制的见解应提出纠正遗传综合征和癌症粘连蛋白PRC1失衡的新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dale L Dorsett其他文献
Dale L Dorsett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dale L Dorsett', 18)}}的其他基金
Cohesin Polycomb Interactions in Gene Regulation
基因调控中的粘连蛋白多梳相互作用
- 批准号:
8611280 - 财政年份:2014
- 资助金额:
$ 29.63万 - 项目类别:
PROJECT III: A Drosophila Model for Cornelia de Lange Syndrome
项目 III:Cornelia de Lange 综合征的果蝇模型
- 批准号:
8378233 - 财政年份:2012
- 资助金额:
$ 29.63万 - 项目类别:
An Animal Model for Cornelia de Lange Syndrome
科妮莉亚·德·朗格综合症的动物模型
- 批准号:
7868900 - 财政年份:2009
- 资助金额:
$ 29.63万 - 项目类别:
A DROSOPHILA MODEL FOR CORNELIA DE LANGE SYNDROME
科妮莉亚·德朗格综合征果蝇模型
- 批准号:
7121453 - 财政年份:2006
- 资助金额:
$ 29.63万 - 项目类别:
Gene Activation by Remote Transcriptional Enhancers
远程转录增强子激活基因
- 批准号:
6706213 - 财政年份:2001
- 资助金额:
$ 29.63万 - 项目类别:
Gene Activation by Remote Transcriptional Enhancers
远程转录增强子激活基因
- 批准号:
6344151 - 财政年份:2001
- 资助金额:
$ 29.63万 - 项目类别:
Gene Activation by Remote Transcriptional Enhancers
远程转录增强子激活基因
- 批准号:
6636677 - 财政年份:2001
- 资助金额:
$ 29.63万 - 项目类别:
Gene Activation by Remote Transcriptional Enhancers
远程转录增强子激活基因
- 批准号:
6520535 - 财政年份:2001
- 资助金额:
$ 29.63万 - 项目类别:
相似国自然基金
氨基酸结合和解离Ubr1的调控机制研究
- 批准号:32300990
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
精准挖掘水稻生长素受体OsAFB4结合生长素类除草剂的关键氨基酸靶点
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
嗜热子囊菌TaAA9A关键氨基酸介导的结晶纤维素结合与降解机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
精准挖掘水稻生长素受体OsAFB4结合生长素类除草剂的关键氨基酸靶点
- 批准号:32201834
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
DeADP-ribosylation of host targets mediated by a bacterial effector
由细菌效应子介导的宿主靶标的 DeADP-核糖基化
- 批准号:
10667971 - 财政年份:2023
- 资助金额:
$ 29.63万 - 项目类别:
Development of peptide drug conjugates for cancer therapy
开发用于癌症治疗的肽药物缀合物
- 批准号:
10760236 - 财政年份:2023
- 资助金额:
$ 29.63万 - 项目类别:
Biotin Orthogonal Streptavidin System (BOSS) for Drug Pre-Targeting
用于药物预靶向的生物素正交链霉亲和素系统 (BOSS)
- 批准号:
10606180 - 财政年份:2023
- 资助金额:
$ 29.63万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 29.63万 - 项目类别: